한빛사507건

• • Athira Raveendran(전남대학교)

  • 서진희(전남대학교, Massachusetts General Hospital and Harvard Medical School)

  • 최학수(Massachusetts General Hospital and Harvard Medical School)

  • 조훈성(전남대학교)

  Lysosome-Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy

  • Adv. Sci. Sep 04 2024, | https://doi.org/10.1002/advs.202401424

  • 2024.09
  • 바이오·의료융합

• • 장연수(연세대학교 의과대학)

  • 조남훈(연세대학교 의과대학)

  • 김백길(연세대학교 의과대학)

  Fibrosis-Encapsulated Tumoroid, A Solid Cancer Assembloid Model for Cancer Research and Drug Screening

  • Adv. Healthc. Mater. Sep 05 2024, | https://doi.org/10.1002/adhm.202402391

  • 2024.09
  • 의약학

• • 장호충(한국과학기술연구원 (KIST))

  • 심만규(한국과학기술연구원 (KIST))

  • 양유수(한국과학기술연구원)

  Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs

  • Theranostics Published 2024-8-26;14(14):5413-5428 | doi:10.7150/thno.97269

  • 2024.08
  • 바이오·의료융합

• • 김민수(University of Rochester Medical Center)

  Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors

  • Proc. Natl. Acad. Sci. USA Aug 27 2024, 121 (35) | https://doi.org/10.1073/pnas.2406748121

  • 2024.08
  • 의약학
• 

  성예원

  NIH

  We study cisplatin, which is a widely used and effective anticancer drug, but it has significant side effects, including ototoxicity (hearing loss) and nephrotoxicity (kidney injury), in pediatric and adult cancer patients. In this paper, we investigated the role of macrophages in cisplatin-induced hearing loss and kidney injury in mice.

  • Sci. Adv.
  • 2024.08.21

• • 김상필(UNIST)

  • 유자형(UNIST)

  Enzyme-instructed intramitochondrial polymerization for enhanced anticancer treatment without the development of drug-resistance

  • J. Control. Release Jul 16 2024, 373 S0168-3659(24)00459-0 | https://doi.org/10.1016/j.jconrel.2024.07.029

  • 2024.07
  • 바이오·의료융합

• • Thoa Thi Kim Nguyen(성균관대학교)

  • 우선민(계명대학교 의과대학)

  • 권택규(계명대학교 의과대학)

  • 육심명(성균관대학교)

  Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer

  • Biomaterials Jul 30 2024, 312 S0142-9612(24)00267-9 | https://doi.org/10.1016/j.biomaterials.2024.122733

  • 2024.07
  • 의약학

• • 성예원(NIH)

    Interview

  Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity

  • Sci. Adv. Jul 26 2024, 10 (30) eadk9878 | https://doi.org/10.1126/sciadv.adk9878

  • 2024.07

• • 김서영(한국과학기술연구원)

  • 김성찬(한국과학기술연구원)

  • 김현경(고려대학교 의과대학)

  • 이효진(한국과학기술연구원)

  Improvement of Therapeutic Effect via Inducing Non-Apoptotic Cell Death Using mRNA-Protection Nanocage

  • Adv. Healthc. Mater. Jul 31 2024, | https://doi.org/10.1002/adhm.202400240

  • 2024.07
  • 바이오·의료융합

• • 조서현(Norwich Research Park)

  Unlocking saponin biosynthesis in soapwort

  • Nat. Chem. Biol. Jul 23 2024, | https://doi.org/10.1038/s41589-024-01681-7

  • 2024.07

• • 전흥진(충남대학교)

  • 임대진(강원대학교 의생명과학대학 의생명융합학부)

  • 정재호(전남대학교 의과대학)

  • 송미령(한국외국어대학교)

  • 이효진(충남대학교 의과대학, 충남대학교병원)

  Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers

  • Acta Pharm. Sin. B Available online 10 July 2024 | https://doi.org/10.1016/j.apsb.2024.07.011

  • 2024.07
  • 의약학

• • 이수삼(KAIST)

  • 홍경희(연세대학교)

  • 고원건(연세대학교)

  • 하상준(연세대학교)

  • 김유천(KAIST)

  Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment

  • J. Control. Release Jul 04 2024, S0168-3659(24)00435-8 | https://doi.org/10.1016/j.jconrel.2024.07.004

  • 2024.07
  • 생명과학

• • 이승락(부산대학교)

  Hirocidins, Cytotoxic Metabolites from Streptomyces hiroshimensis, Induce Mitochondrion-mediated Apoptosis

  • Angew. Chem.-Int. Edit. Jun 19 2024, | https://doi.org/10.1002/anie.202405367

  • 2024.06
  • 의약학

• • 김누리(전북대학교)

  • 이동원(전북대학교)

  Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin

  • J. Control. Release Volume 369, May 2024, Pages 351-362 | https://doi.org/10.1016/j.jconrel.2024.03.046

  • 2024.05
  • 바이오·의료융합

• • 황인영(National University of Singapore)

  • 장욱(National University of Singapore)

  Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy

  • Nat. Commun. 21 May 2024 | https://doi.org/10.1038/s41467-024-48661-y

  • 2024.05

• • Thienle(성균관대학교 약학대학)

  • 윤유석(성균관대학교 약학대학)

  Peroxidase?Mimicking Iron?Based Single?Atom Upconversion Photocatalyst for Enhancing Chemodynamic Therapy

  • Adv. Funct. Mater. 27 May 2024 | https://doi.org/10.1002/adfm.202401893

  • 2024.05
  • 의약학

• • 양장우(POSTECH)

  • 이재윤(POSTECH)

  • 차형준(POSTECH)

  Acrylated adhesive proteinic microneedle patch for local drug delivery and stable device implantation

  • J. Control. Release Available online 30 May 2024 | https://doi.org/10.1016/j.jconrel.2024.05.038

  • 2024.05
  • 바이오·의료융합

• • 오도연(서울대학교 의과대학, 서울대학교병원)

  Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarci

  • Br. Med. J. May 28 2024, 385 | https://doi.org/10.1136/bmj-2023-078876

  • 2024.05

• • 이유연(연세대학교)

  • 남건욱(연세대학교)

  • 노영훈(연세대학교)

  Functional polymeric DNA nanostructure-decorated cellulose nanocrystals for targeted and stimuli-responsive drug delivery

  • Carbohydr. Polym. Available online 14 May 2024 | https://doi.org/10.1016/j.carbpol.2024.122270

  • 2024.05
  • 바이오·의료융합

• • 김성은(한국과학기술연구원(KIST))

  • 도준상(서울대학교)

  • 김홍남(한국과학기술연구원(KIST))

  Imaging-based Efficacy Evaluation of Cancer Immunotherapy in Engineered Tumor Platforms and Tumor Organoids

  • Adv. Healthc. Mater. May 30 2024, | https://doi.org/10.1002/adhm.202400475

  • 2024.05
  • 바이오·의료융합